Skip to main content

Table 3 The risk mutations of Brugada syndrome and long QT syndrome

From: Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel

ID

DS

Chr

Start

Gene

Amino acid change

Het

1000 g/Esp

SIFT

Polyphen

Clinic

ACMG

Evidence

dbSNP

1

Brs

chr1

3,342,629

PRDM16

PNM_199454:exon14:c.G3124A:p.G1042R

 ± 

0.00(D)

1.00(D)

VUS

PM2_Supporting

  

chr10

21,097,556

NEBL

NM_006393:exon26:c.C2644T:p.R882X

 ± 

 < 0.001

VUS

VUS

PM2_Supporting

rs151012132

  

chr2

179,447,747

TTN

NM_003319:exon141:c.G38588A:p.R12863Q

 ± 

0.04(D)

1.00(D)

VUS

VUS

PM2_Supporting

  

chr2

179,460,249

TTN

NM_003319:exon123:c.A30637G:p.I10213V

 ± 

0.36(T)

0.95(D)

VUS

PM2_Supporting

rs56025724

  

chr21

18,919,405

CXADR

NM_001207063:exon2:c.A104G:p.E35G

 ± 

0.05(T)

1.00(D)

VUS

PM2_Supporting

3

Brs

chr1

11,907,301

NPPA

NM_006172:exon2:c.C319T:p.R107X

 ± 

LP

PM2_Supporting, PVS1

  

chr1

228,467,100

OBSCN

NM_001098623:exon27:c.T7351G:p.F2451V

 ± 

0.27(T)

0.93(D)

VUS

PM2_Supporting

  

chr1

228,547,344

OBSCN

NM_052843:exon81:c.C18751T:p.R6251W

 ± 

0.02(D)

0.74(P)

VUS

PM2_Supporting

  

chr1

228,559,174

OBSCN

NM_001098623:exon94:c.C20695T:p.R6899W

 ± 

0.00(D)

0.64(P)

VUS

PM2_Supporting

  

chr2

179,640,347

TTN

NM_003319:exon27:c.G6106A:p.E2036K

 ± 

0.27(T)

1.00(D)

VUS

PM2_Supporting

4

Brs

chr12

114,793,662

TBX5

NM_080717:exon8:c.C1082T:p.T361I

 ± 

 < 0.001

0.13(T)

0.46(P)

VUS

PM2_Supporting

rs267603320

  

chr2

179,432,053

TTN

NM_003319:exon154:c.C51611T:p.S17204F

 ± 

0.00(D)

0.84(P)

VUS

PM2_Supporting

6

Brs

chr15

39,885,760

THBS1

NM_003246:exon19:c.C3158T:p.T1053M

 ± 

 < 0.001

0.02(D)

0.71(P)

VUS

PM2_Supporting

rs267604168

  

chr17

39,915,014

JUP

NM_002230:exon9:c.C1606G:p.Q536E

 ± 

0.03(D)

0.30(B)

VUS

PM2_Supporting

  

chr3

71,015,109

FOXP1

NM_001244813:exon14:c.C1521G:p.N507K

 ± 

0.04(D)

0.83(P)

VUS

PM2_Supporting

7

Brs

chr19

16,593,346

CALR3

NM_145046:exon7:c.G833A:p.R278H

 ± 

0.03(D)

0.00(B)

VUS

PM2_Supporting

  

chr21

18,937,961

CXADR

NM_001338:exon7:c.C1049T:p.A350V

 ± 

0.102(T)

0.949(D)

VUS

PM2_Supporting

  

chr4

111,539,442

PITX2

NM_000325:exon3:c.G814A:p.A272T

 ± 

0.41(T)

0.95(D)

VUS

PM2_Supporting

  

chr5

251,519

SDHA

NM_001294332:exon12:c.A1586C:p.Q529P

 ± 

0.02(D)

0.99(D)

VUS

PM2_Supporting

9

Brs

chr5

37,333,576

NUP155

NM_001278312:exon13:c.C1507T:p.L503F

 ± 

0.01(D)

1.00(D)

VUS

PM2_Supporting

  

chr7

128,481,334

FLNC

NM_001127487:exon12:c.G1924A:p.V642I

 ± 

 < 0.001

0.82(T)

0.67(P)

VUS

PM2_Supporting

rs369387744

12

Brs

chr10

112,581,622

RBM20

NM_001134363:exon11:c.T3245G:p.L1082R

 ± 

0.00(D)

0.08(B)

VUS

PM2_Supporting

  

chr20

33,345,504

NCOA6

NM_001242539:exon7:c.G1047C:p.L349F

 ± 

0.02(D)

0.89(P)

VUS

PM2_Supporting

14

LQTs

chr1

228,467,732

OBSCN

NM_001098623:exon28:c.G7607C:p.G2536A

 ± 

0.01(D)

1.00(D)

VUS

PM2_Supporting

  

chr3

38,739,348

SCN10A

NM_001293307:exon26:c.T5069C:p.M1690T

 ± 

0.00(D)

0.99(D)

VUS

PM2_Supporting

  

chr3

38,770,058

SCN10A

NM_001293307:exon14:c.C2321T:p.T774M

 ± 

0.93(T)

0.02(B)

VUS

PM2_Supporting

  

chr7

150,655,499

KCNH2

NM_000238:exon4:c.563_564del:p.A188Gfs*143

±

LP

PM2_Supporting, PVS1

15

Brs

chr14

23,853,757

MYH6

NM_002471:exon36:c.G5459A:p.R1820Q

 ± 

 < 0.001

0.01(D)

1.00(D)

VUS

PM2_Supporting

rs371222772

  

chr19

39,406,284

SARS2

NM_017827:exon16:c.C1519T:p.R507W

 ± 

 < 0.001

0.01(D)

0.54(P)

VUS

PM2_Supporting

rs143316017

  

chr6

152,472,791

SYNE1

NM_033071:exon134:c.C24134T:p.A8045V

 ± 

0.12(T)

0.98(D)

VUS

PM2_Supporting

16

Brs

chr14

74,970,636

LTBP2

NM_000428:exon31:c.4573_4575del:p.1525_1525del

 ± 

VUS

PM2_Supporting, PM4_Supporting

  

chr2

179,453,729

TTN

NM_003319:exon132:c.G35528A:p.R11843Q

 ± 

0.001

0.10(T)

1.00(D)

VUS

PM2_Supporting

rs377203669

  

chr2

179,455,524

TTN

NM_003319:exon132:c.C33733T:p.R11245C

 ± 

0.001

0.00(D)

1.00(D)

VUS

PM2_Supporting

rs200898955

  

chr7

140,624,425

BRAF

NM_004333:exon1:c.G79A:p.A27T

 ± 

0.57(T)

0.48(P)

VUS

PM2_Supporting

  

chr8

106,573,686

ZFPM2

NM_012082:exon4:c.A397G:p.M133V

 ± 

0.60(T)

0.01(B)

VUS

PM2_Supporting

rs77117583

17

Brs

chr1

228,547,680

OBSCN

NM_052843: exon81:c.G19087A:p.G6363S

 ± 

 

1.00(T)

0.02(B)

VUS

PM2_Supporting

  

chr14

23,883,054

MYH7

NM_000257: exon39:c.G5704C:p.E1902Q

 ± 

 < 0.001

0.08(D)

0.61(P)

VUS

PM2_Supporting

rs187073962

20

Brs

chr6

112,506,509

LAMA4

NM_001105206:exon9:c.A1007G:p.K336R

 ± 

0.57(T)

0.52(P)

VUS

PM2_Supporting

  1. DS diseases, LQTs long QT syndrome, Brs Brugada syndrome, Chr chromosome, 1000G/Esp 1000genomes (2015 version) or Esp6500 database, SNP single nucleotide polymorphism, PP polyphen-2, D damaging, B benign, T tolerated, ± heterozygous carrier, P pathogenic, LP likely pathogenic, – no report